Novità nel mondo di Medicina di Laboratorio

The Week That Wasn't: Cold Cure, Sickle Cell, Polluted Placenta

Pathology & Lab Medicine - Medscape - Gio, 26/09/2019 - 04:23
Three medical stories that we didn't cover, explained.
Medscape

IUD Use Linked to Reduced Risk of Ovarian Cancer

Pathology & Lab Medicine - Medscape - Gio, 26/09/2019 - 04:23
Women who use an intrauterine device for contraception have a reduced risk of getting ovarian cancer, according to a new meta-analysis of existing retrospective data.
Medscape Medical News

Can Video Gaming Trigger Dangerous Arrhythmias?

Pathology & Lab Medicine - Medscape - Gio, 26/09/2019 - 04:23
Ventricular arrhythmias are typically exacerbated by physical exercise, but a new case series suggests even sedentary activities may increase the risk in children with certain conditions.
Medscape Medical News

Novel TAVR Approach Dramatically Cuts Need for Pacemaker

Pathology & Lab Medicine - Medscape - Gio, 26/09/2019 - 04:23
TAVR carries risk of postprocedure pacemaker implantation. A new technique using the patient's individual anatomy to determine device location may decrease this complication, a new study suggests.
Medscape Medical News

Hypertension Linked to Cognitive Decline, but Treatment Helps

Pathology & Lab Medicine - Medscape - Gio, 26/09/2019 - 04:23
In a large Chinese population study, the treatment of hypertension was linked to a slower progression of cognitive decline.
Medscape Medical News

EAN Guidelines Endorse Early Palliative Care Dialogue in MS

Pathology & Lab Medicine - Medscape - Gio, 26/09/2019 - 04:23
Both specialists and general practitioners caring for people with severe MS and their families should discuss palliative care options in advance, new guidelines emphasize.
Medscape Medical News

New Data on Natalizumab During Pregnancy in MS

Pathology & Lab Medicine - Medscape - Mer, 25/09/2019 - 03:23
Women with multiple sclerosis who continued to receive the drug during pregnancy had a much lower risk of relapses, according to a new Italian observational study.
Medscape Medical News

Point-of-Care Testing Useful for Newborn Sickle Cell Screening

Pathology & Lab Medicine - Medscape - Mer, 25/09/2019 - 03:23
Point-of-care testing is useful for newborn screening for sickle cell disease (SCD) in low-income settings, according to results from an observational study.
Reuters Health Information

Recommended TSH Norm for Patients on Thyroxine Shows No Ill Effect

Pathology & Lab Medicine - Medscape - Mer, 25/09/2019 - 03:23
Recommended "normal" thyroid-stimulating hormone (TSH) concentrations for hypothyroid patients receiving thyroxine are not associated with increased risk of cardiovascular disease, fractures, or all-cause mortality, according to new findings.
Reuters Health Information

Blood Lipid Changes at Age 8 in Kids Genetically Prone to Diabetes

Pathology & Lab Medicine - Medscape - Mar, 24/09/2019 - 02:23
Children who have a high genetic risk score for adult type 2 diabetes also appear to have lower levels of HDL, or 'good' cholesterol, as early as age 8.
Medscape Medical News

Reimagining STI Clinics for a New Generation

Pathology & Lab Medicine - Medscape - Mar, 24/09/2019 - 02:23
Clinics that are designed to be stylish, easy to access, and efficient are changing the way cities tackle STI testing and treatment.
Medscape Medical News

What Do You Think About Hospital Data Partnerships With Big Tech?

Pathology & Lab Medicine - Medscape - Mar, 24/09/2019 - 02:23
Under a new 10-year partnership, the Mayo Clinic will store patient data with Google Cloud and use the tech giant's technology to develop new healthcare tools.
Medscape Reader Polls

Retinopathy Associated With Topical Oral Corticosteroid Use

Pathology & Lab Medicine - Medscape - Mar, 24/09/2019 - 02:23
Central serous retinopathy has been reported following systemic corticosteroid use. Might a topical corticosteroid used for dental treatment be the cause of this patient's central serous retinopathy?
Journal of Medical Case Reports

Small Prolonged Reductions in LDL, BP Substantially Reduce CV Risk

Pathology & Lab Medicine - Medscape - Lun, 23/09/2019 - 01:23
A new Mendelian randomization study shows the large benefits that could be achieved from small reductions in cholesterol and blood pressure if maintained over a lifetime.
Medscape Medical News

US, Canada, Australia Approve Endometrial Cancer Combo

Pathology & Lab Medicine - Medscape - Lun, 23/09/2019 - 01:23
Regulatory agencies in three countries, including the United States, all approved lenvatinib in combination with pembrolizumab for the treatment of patients with advanced endometrial carcinoma.
FDA Approvals

USPSTF Finds Evidence Insufficient for Routine MCI Screening

Pathology & Lab Medicine - Medscape - Lun, 23/09/2019 - 01:23
Should asymptomatic older adults be screened for incipient dementia? No, according to this draft recommendation released by the USPSTF.
Medscape Medical News

Race, Income May Impact U.S. Oral Cancer Screening Rates

Pathology & Lab Medicine - Medscape - Lun, 23/09/2019 - 01:23
Only about 1 in 3 U.S. adults say a dentist has ever examined them for oral cancer - and most of those who remember getting such exams are non-Hispanic whites, a new study suggests.
Reuters Health Information

Underserved Communities Receive Hep C Treatment in Jail

Pathology & Lab Medicine - Medscape - Ven, 20/09/2019 - 23:23
The testing and treatment of inmates for hepatitis C can be effective, but system efficiencies, perceptions, and limits on care after release can present obstacles.
Medscape Medical News

Obesity Poses Much Bigger Risk for Diabetes Than Bad Genes

Pathology & Lab Medicine - Medscape - Gio, 19/09/2019 - 22:23
The study highlights the dominance of obesity as a risk factor for type 2 diabetes and reinforces the "importance of weight management in diabetes prevention...in all genetic risk groups," say researchers.
Medscape Medical News

Ofatumumab Impresses in MS; Competition for Ocrelizumab Soon?

Pathology & Lab Medicine - Medscape - Gio, 19/09/2019 - 22:23
A new B cell-depleting therapy, given as a monthly subcutaneous injection, has shown impressive results in two phase 3 studies in relapse-remitting multiple sclerosis.
Medscape Medical News
Condividi contenuti